A cholangiocarcinoma cell line with high HER2 expression demonstrated enhanced invasiveness, motility, and proliferation compared with the other cell lines without HER2 overexpression via AKT/p70S6K pathway activation [10]. This evidence concerns the gene ERBB2 and cholangiocarcinoma.